Xiaoxin Xie
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Metabolic and Immunological Trajectories and Virological Outcomes of Ainuovirine-Based Antiretroviral Therapy: A 48-Week Longitudinal Cohort Study in Treatment-Naïve Adults.
Journal: Journal of medical virology
Published: December 30, 2025
Safety, pharmacokinetics, and efficacy of albuvirtide administered by intravenous bolus every 4 weeks in combination with oral dolutegravir in virologically suppressed adults living with HIV: A 24-week study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: September 24, 2025
Enhancing HIV Genotyping and Drug-Resistance Detection in Low Viral Load Samples Through Exosome Enrichment Technology.
Journal: AIDS research and human retroviruses
Published: September 02, 2025
Efficacy and safety of dolutegravir plus lamivudine for patients with late presentation of HIV-1 infection: a retrospective real-world cohort study in Southwest China.
Journal: Frontiers in medicine
Published: May 19, 2025
Clinical Characteristics of Patients With AIDS and Talaromyces marneffei Infection of the Central Nervous System: A Retrospective Observation Study.
Journal: AIDS research and treatment
Published: February 24, 2025
Clinical Efficacy and Safety of BIC/TAF/FTC in Elderly HIV-Infected Individuals in Southwest China: A Retrospective Observation Study.
Journal: Immunity, inflammation and disease
Published: December 24, 2024
Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study.
Journal: AIDS (London, England)
Published: October 21, 2024
Efficacy of Dolutegravir Plus Lamivudine in People With TB/HIV Co-Infection Using a Rifampicin or Rifabutin-Based Regimen: A Retrospective Observational Case Series.
Journal: Immunity, inflammation and disease
Published: August 27, 2024
Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Late-Presenting People With HIV-1 Infection.
Journal: Open forum infectious diseases
Published: July 31, 2024
Comparative Studies on the Efficacy and Safety of Ainuovirine-Based Versus Efavirenz-Based Antiretroviral Therapy in the Management of Persons Living with HIV: A Real-World Study in Guizhou, China.
Journal: AIDS research and human retroviruses
Published: May 16, 2024
Efficacy and effect on lipid profiles of Ainuovirine-based regimen versus Efavirenz-based regimen in treatment-naïve people with HIV-1 at week 24: A real-world, retrospective, multi-center cohort study.
Journal: Bioscience trends
Published: April 29, 2024
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide fumarate for adult patients with human immunodeficiency virus-1 in China: a retrospective real-world cohort study.
Journal: Expert review of anti-infective therapy
Published: December 07, 2023
Last Updated: 09/26/2026